Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inne H M Borel-Rinkes

Showing results (71-80 of 215) with videos related to

Pageof 22
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 11, 2012
Robot-assisted pancreatic surgery: a systematic review of the literatureMarin Strijker, Hjalmar C van Santvoort, Marc G Besselink, et al.
World Journal of Surgical Oncology|October 10, 2007
A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2CJennifer M J Schreinemakers, Bernard A Zonnenberg, Jo W M Höppener, et al.
Gastroenterology|May 13, 2015
Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor CellsSzabolcs Fatrai, Susanne J van Schelven, Inge Ubink, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 24, 2010
Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibitionWinan J van Houdt, Menno T de Bruijn, Benjamin L Emmink, et al.
Surgery|May 5, 2019
Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patientsWessel M C M Vorselaars, Dirk-Jan van Beek, Emily L Postma, et al.
Anticancer Research|April 22, 2011
Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancerMenno T De Bruijn, Daniëlle A E Raats, Jolien Tol, et al.
Annals of Surgical Oncology|March 25, 2025
Rare but Complex: Outcomes and Challenges in Managing Composite Follicular-Anaplastic Thyroid CancerDilay Aykan, Hala Al Asadi, Anjani Turaga, et al.
World Journal of Surgery|September 7, 2019
Correction to: Validation of the Aldosteronoma Resolution Score Within Current Clinical PracticeWessel M C M Vorselaars, Dirk-Jan van Beek, Emily L Postma, et al.
Cancer Research|May 19, 2006
KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligandNiels Smakman, Diana J M van den Wollenberg, Sjoerd G Elias, et al.
World Journal of Surgery|July 5, 2019
Validation of the Aldosteronoma Resolution Score Within Current Clinical PracticeWessel M C M Vorselaars, Dirk-Jan van Beek, Emily L Postma, et al.
Pageof 22

Showing results (71-80 of 215) with videos related to

Sort By:
Pageof 22
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 11, 2012
Robot-assisted pancreatic surgery: a systematic review of the literatureMarin Strijker, Hjalmar C van Santvoort, Marc G Besselink, et al.
World Journal of Surgical Oncology|October 10, 2007
A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2CJennifer M J Schreinemakers, Bernard A Zonnenberg, Jo W M Höppener, et al.
Gastroenterology|May 13, 2015
Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor CellsSzabolcs Fatrai, Susanne J van Schelven, Inge Ubink, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 24, 2010
Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibitionWinan J van Houdt, Menno T de Bruijn, Benjamin L Emmink, et al.
Surgery|May 5, 2019
Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patientsWessel M C M Vorselaars, Dirk-Jan van Beek, Emily L Postma, et al.
Anticancer Research|April 22, 2011
Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancerMenno T De Bruijn, Daniëlle A E Raats, Jolien Tol, et al.
Annals of Surgical Oncology|March 25, 2025
Rare but Complex: Outcomes and Challenges in Managing Composite Follicular-Anaplastic Thyroid CancerDilay Aykan, Hala Al Asadi, Anjani Turaga, et al.
World Journal of Surgery|September 7, 2019
Correction to: Validation of the Aldosteronoma Resolution Score Within Current Clinical PracticeWessel M C M Vorselaars, Dirk-Jan van Beek, Emily L Postma, et al.
Cancer Research|May 19, 2006
KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligandNiels Smakman, Diana J M van den Wollenberg, Sjoerd G Elias, et al.
World Journal of Surgery|July 5, 2019
Validation of the Aldosteronoma Resolution Score Within Current Clinical PracticeWessel M C M Vorselaars, Dirk-Jan van Beek, Emily L Postma, et al.
Pageof 22